Table 4 Hodgkin's lymphoma CTA expression analysis.
Clinical data | N | 0 CTA (%) | N | > or = 1 CTA (%) | p value |
|---|---|---|---|---|---|
HL Subtype | |||||
Nodular sclerosis | 19 | 76.0 | 6 | 24.0 | 0.752 |
Mixed cellularity | 7 | 77.8 | 2 | 22.2 | |
Lymphocyte predominant | 2 | 100.0 | 0 | 0 | |
Unclassified | 2 | 100.0 | 0 | 0 | |
Ann Arbor staging | |||||
Early (I or II) | 15 | 88.2 | 2 | 11.8 | 0.195 |
Advanced (III or IV) | 15 | 71.4 | 6 | 28.6 | |
EBV status | |||||
Negative | 17 | 81.0 | 4 | 19.0 | 0.522 |
Positive | 13 | 76.5 | 4 | 23.5 | |
Treatment Response | |||||
Complete response | 24 | 80.0 | 6 | 20.0 | 0.954 |
Non Complete response | 6 | 75.0 | 2 | 25.0 |